Attrax putty nuvasive
Web"A study of this quality immediately differentiates Attrax Putty from other biologics on the market," said Matt Link, president of NuVasive."Attrax has proven the critical role surface optimization plays in the effectiveness of bone grafting technology, and underscores the NuVasive approach to developing innovative solutions which deliver positive clinical … WebNuvasive Inc: 03/20/2024: 7:00AM: PR Newswire (US) NuVasive Specialized Orthopedics Expands Indications of Precice Limb Lengthening System to Treat Pediatric Patients: NASDAQ:NUVA: Nuvasive Inc ...
Attrax putty nuvasive
Did you know?
WebFeb 28, 2024 · February 28, 2024. The FDA has cleared an expanded indication of a combination of NuVasive’s Modulus Cervical interbody implant with Attrax Putty bone void filler. Attrax Putty is the first synthetic bone graft substitute to receive FDA clearance for use in thoracolumbar interbody fusion spacers. The devices are part of the company’s C360 ... WebMar 5, 2024 · – Attrax Putty is now the first and only ceramic bone graft substitute supported by Level I evidence to demonstrate non-inferior fusion performance compared to autograft 1 –. SAN DIEGO – March 5, 2024 – NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally …
WebJan 10, 2024 · NuVasive's (NUVA) Attrax Putty is the first and only synthetic biologic to receive 510(k) indications for use in interbody fusions of the thoracolumbar spine. WebFeb 21, 2024 · Feb 21, 2024, 07:00 ET. Attrax Putty is now on-label for use with cervical Modulus interbody implants. SAN DIEGO, Feb. 21, 2024 /PRNewswire/ -- NuVasive, Inc. …
WebFeb 21, 2024 · Attrax Putty is now on-label for use with cervical Modulus interbody implants. SAN DIEGO, Feb. 21, 2024 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that it received … WebFeb 21, 2024 · Attrax Putty is now on-label for use with cervical Modulus interbody implants. SAN DIEGO, Feb. 21, 2024 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that it received …
WebJan 10, 2024 · NuVasive's (NUVA) Attrax Putty is the first and only synthetic biologic to receive 510(k) indications for use in interbody fusions of the thoracolumbar spine.
WebNuVasive 102,086 followers 4mo Modulus XLIF and Attrax Putty showed high rates of success and low rates of complications (1) in a study where 90 patients were treated at 136 thoracolumbar levels. ... clog\\u0027s syWebOct 3, 2024 · NuVasive AttraX Putty. is a synthetic, osteoconductive and resorbable bone void filler device consisting of ceramic granules premixed with a polymeric binder that provides cohesion between the granules. Pressure applied by user manipulation allows the AttraX Putty to be molded into specific shapes, mixed with autograft, or contoured into a … clog\\u0027s t4WebThe publication of these results further reinforces NuVasive’s position as a leader in the spine market, offering innovative solutions to support positive clinical outcomes. Attrax … tartarughe ninja giochi onlineWebFeb 21, 2024 · Attrax Putty is now on-label for use with cervical Modulus interbody implants. SAN DIEGO, Feb. 21, 2024 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation ... clog\\u0027s t1WebNov 6, 2024 · predicates NuVasive AttraX Putty (K151584) and NuVasive AttraX Granules1 (K090641). D. Device Description The subject AttraX Scaffold, is an osteoconductive and resorbable bone void filler designed for use in the skeletal system. AttraX Scaffold consists of ceramic granules premixed with purified type I bovine collagen. tartarughe ninja film anni 90 streamingWebNov 13, 2013 · This product is AttraX® Putty (CE-557130), a bioresorbable tricalcium phosphate (TCP), mixed with a fast resorbing polymer carrier to improve surgical handling. The aim of the current study is to clinically investigate AttraX® Putty as an alternative to autologous bone graft in adult patients qualified for instrumented posterolateral fusion ... clog\\u0027s t7WebThe publication of these results further reinforces NuVasive’s position as a leader in the spine market, offering innovative solutions to support positive clinical outcomes. Attrax Putty is a synthetic, bioactive and osteoconductive bone void filler for … clog\\u0027s t5